CIK 0001582313
- Large accelerated filer
Xenon Pharmaceuticals Inc.
Sign in to watch- Ticker
- XENE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- Operating
- EIN
- 980661854
- Phone
- +1 604-484-3300
- Business address
- 200 - 3650 GILMORE WAY, BURNABY, British Columbia, Canada
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Director sold 131,245 shares at an average $38.90 ($5,104,970)
- 4 Open-market sale PRESIDENT & CEO sold 31,655 shares at an average $41.41 ($1,310,931)
- 4 Open-market sale Chief Medical Officer sold 700 shares at $35.01 ($24,507)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Director sold 19,232 shares at an average $36.98 ($711,199)
- 4 Exercise or conversion Director acquired 3,086 shares (option exercise)
- 4 Open-market sale Director sold 3,994 shares at an average $34.55 ($138,000)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Chief Financial Officer sold 15,355 shares at $39.57 ($607,597)
- 4 Open-market sale EVP, Strategy & Innovation sold 65,231 shares at an average $38.31 ($2,499,023)
- 4 Open-market sale EVP, Drug Discovery sold 57,743 shares at an average $38.31 ($2,211,978)
- 4 Open-market sale Director sold 177,135 shares at an average $38.25 ($6,775,149)
Page 5 of 19 · 370 filings